These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 15727089)

  • 21. Glycoprotein IIB/IIIA inhibitor to reduce postpercutaneous coronary intervention myonecrosis and improve coronary flow in diabetics: the 'OPTIMIZE-IT' pilot randomized study.
    Talarico GP; Brancati M; Burzotta F; Porto I; Trani C; De Vita M; Todaro D; Giammarinaro M; Leone AM; Niccoli G; Andreotti F; Mazzari MA; Schiavoni G; Crea F
    J Cardiovasc Med (Hagerstown); 2009 Mar; 10(3):245-51. PubMed ID: 19262211
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Health related quality of life after percutaneous coronary intervention versus coronary artery bypass graft surgery in patients with acute coronary syndromes without ST-segment elevation. 12-month follow up.
    Szygula-Jurkiewicz B; Zembala M; Wilczek K; Wojnicz R; Polonski L
    Eur J Cardiothorac Surg; 2005 May; 27(5):882-6. PubMed ID: 15848330
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of stenting and surgical revascularization strategy in non-ST elevation acute coronary syndromes and complex coronary artery disease (from the Milestone Registry).
    Buszman PE; Buszman PP; Bochenek A; Gierlotka M; Gąsior M; Milewski K; Orlik B; Janas A; Wojakowski W; Kiesz RS; Zembala M; Poloński L
    Am J Cardiol; 2014 Oct; 114(7):979-87. PubMed ID: 25124186
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Usefulness of TIMI Risk Score in assessing the prognosis in patients with acute coronary syndromes without ST elevation assigned to early percutaneous coronary intervention. Comparison of the high-risk and the moderate-risk patients].
    Szyguła-Jurkiewicz B; Wilczek K; Trzeciak P; Poloński L
    Pol Arch Med Wewn; 2004 Sep; 112(3):1083-91. PubMed ID: 15727090
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diabetes mellitus: the major risk factor in unstable coronary artery disease even after consideration of the extent of coronary artery disease and benefits of revascularization.
    Norhammar A; Malmberg K; Diderholm E; Lagerqvist B; Lindahl B; Rydén L; Wallentin L
    J Am Coll Cardiol; 2004 Feb; 43(4):585-91. PubMed ID: 14975468
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early administration of abciximab in patients with acute myocardial infarction improves angiographic and clinical outcome after primary angioplasty.
    Beeres SL; Oemrawsingh PV; Warda HM; Bechan R; Atsma DE; Jukema JW; van der Wall EE; Schalij MJ
    Catheter Cardiovasc Interv; 2005 Aug; 65(4):478-83. PubMed ID: 15973655
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of angina prior to acute ST-elevation myocardial infarction on short-term outcomes after primary percutaneous coronary intervention: results from the Shanghai Registry of Acute Coronary Syndrome (SRACE).
    Zhang Q; Zhang RY; Zhu TQ; Hu J; Yang ZK; Ding FH; Du R; Zhu ZB; Shen WF
    Chin Med J (Engl); 2012 Mar; 125(6):977-82. PubMed ID: 22613517
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of platelet and inflammatory system activation on outcomes in diabetic patients with ST segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Kuliczkowski W; Greif M; Gąsior M; Kaczmarski J; Pres D; Poloński L
    Kardiol Pol; 2011; 69(6):531-7. PubMed ID: 21678284
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of glycoprotein IIb/IIIa inhibitors in invasively-treated patients with non-ST elevation acute coronary syndrome.
    De Servi S; Mariani M; Vandoni P; Dellavalle A; Politi A; Poletti F; Bonizzoni E; Leoncinie M;
    J Cardiovasc Med (Hagerstown); 2006 Mar; 7(3):159-65. PubMed ID: 16645379
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spontaneous reperfusion before intervention improves immediate but not long-term prognosis in diabetic patients with ST-segment elevation myocardial infarction and multivessel coronary artery disease.
    Lekston A; Hudzik B; Szkodziński J; Gąsior M; Tajstra M; Kalarus Z; Szyguła-Jurkiewicz B; Poloński L
    Cardiol J; 2013; 20(4):378-84. PubMed ID: 23913456
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Repolarization parameters in patients with acute ST segment elevation myocardial infarction treated with primary percutaneous coronary intervention with respect to predischarge ST-T pattern: a preliminary study.
    Szydło K; Wita K; Trusz-Gluza M; Zawada K; Piecuch A; Kulach A; Kucz E; Tyrka A; Kornacka I; Trams-Stawowska P; Pieda G
    Cardiol J; 2009; 16(1):52-6. PubMed ID: 19130416
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Facilitated percutaneous coronary intervention (PCI) in patients with acute ST-elevation myocardial infarction: comparison of prehospital tirofiban versus fibrinolysis before direct PCI.
    Möckel M; Bocksch W; Strohm S; Kühnle Y; Vollert J; Nibbe L; Dietz R
    Int J Cardiol; 2005 Aug; 103(2):193-200. PubMed ID: 16080980
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improved in-hospital outcomes in acute coronary syndromes (unstable angina/non-ST segment elevation myocardial infarction) despite similar TIMI risk scores.
    Almeda FQ; Hendel RC; Nathan S; Meyer PM; Calvin JE; Klein LW
    J Invasive Cardiol; 2003 Sep; 15(9):502-6. PubMed ID: 12947210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Results of percutaneous coronary interventions in patients > or =90 years of age.
    Teplitsky I; Assali A; Lev E; Brosh D; Vaknin-Assa H; Kornowski R
    Catheter Cardiovasc Interv; 2007 Dec; 70(7):937-43. PubMed ID: 17621664
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial.
    Ferguson JJ; Califf RM; Antman EM; Cohen M; Grines CL; Goodman S; Kereiakes DJ; Langer A; Mahaffey KW; Nessel CC; Armstrong PW; Avezum A; Aylward P; Becker RC; Biasucci L; Borzak S; Col J; Frey MJ; Fry E; Gulba DC; Guneri S; Gurfinkel E; Harrington R; Hochman JS; Kleiman NS; Leon MB; Lopez-Sendon JL; Pepine CJ; Ruzyllo W; Steinhubl SR; Teirstein PS; Toro-Figueroa L; White H;
    JAMA; 2004 Jul; 292(1):45-54. PubMed ID: 15238590
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of platelet glycoprotein IIb/IIIa receptor inhibitors on outcomes of diabetic patients undergoing percutaneous coronary interventions using sirolimus-eluting stents.
    Nikolsky E; Holmes DR; Mehran R; Dangas G; Schampaert E; Morice MC; Schofer J; Sousa JE; Fahy M; Na Y; Donohoe DJ; Moses JW; Leon MB
    Catheter Cardiovasc Interv; 2008 Jun; 71(7):896-906. PubMed ID: 18498145
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Revascularization and prognosis in female patients with non-ST-segment elevation acute coronary syndromes.
    Timóteo AT; Ferreira J; Aguiar C; Almeida Mde S; Ribeiro MA; Cavaco DM; Trabulo M; Seabra-Gomes R
    Rev Port Cardiol; 2003 Mar; 22(3):367-74. PubMed ID: 12847878
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical outcome of patients with diabetes presenting with ST-elevation myocardial infarction and treated with concomitant use of glycoprotein IIb/IIIa inhibitors.
    Kralev S; Krause B; Papavassiliu T; Lang S; Haghi D; Kälsch T; Dempfle CE; Borggrefe M; Süselbeck T
    Cardiol J; 2009; 16(3):234-40. PubMed ID: 19437397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of percutaneous coronary interventions in patients with non ST segment elevation acute coronary syndrome in catheterisation laboratory without on-site surgical back-up.
    Dudek D; Rakowski T; Legutko J; Mielecki W; Dziewierz A; Bartuś S; Rzeszutko Ł; Sadowski J; Zmudka K; Dubiel JS
    Kardiol Pol; 2003 May; 58(5):356-65; discussion: 365. PubMed ID: 14523483
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of abciximab and eptifibatide on angiographic and clinical outcomes in rescue percutaneous coronary intervention for failed fibrinolytic therapy.
    Bajaj RR; Mohammad A; Hong T; Irfan A; Sharieff W; Bagnall A; Christie JA; Kutryk MJ; Chisholm RJ; Cheema AN
    J Invasive Cardiol; 2010 Aug; 22(8):347-52. PubMed ID: 20679668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.